| Kerri Daunis, CRNA | |
|
35 Medical Center Pkwy Ste 201, Augusta, ME 04330-8160 | |
| (207) 620-1136 | |
| (207) 430-4020 |
| Full Name | Kerri Daunis |
|---|---|
| Gender | Female |
| Speciality | |
| Experience | Years |
| Location | 35 Medical Center Pkwy Ste 201, Augusta, Maine |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1750762951 | NPI | - | NPPES |
| Mailing Address | Practice Location Address |
|---|---|
| Kerri Daunis, CRNA 14 Captains Way Unit 303, Brunswick, ME 04011-5107 Ph: (203) 725-6037 | Kerri Daunis, CRNA 35 Medical Center Pkwy Ste 201, Augusta, ME 04330-8160 Ph: (207) 620-1136 |
News Archive
Care Investment Trust Inc., a real estate investment and finance company that invests in healthcare-related real estate, today reported financial results for the fourth quarter and full year ended December 31, 2011, and announced that it has declared a quarterly dividend of $0.135 per share for the fourth quarter 2011.
Wolters Kluwer, a market leader in the professional health content and clinical decision support market, today announced a plan to divest its Pharma-related business. The company is well-positioned to benefit from healthcare reform trends globally to support the Health division's growth strategy.
Paul Greengard, Ph.D.,a Nobel Laureate researcher says that mice deficient in a protein, called p11, display depression-like behaviours, while those with sufficient amounts behave as if they have been treated with antidepressants.
Scientists at Rutgers University have developed a targeted drug delivery system that they believe could make ovarian cancer more treatable and increase survival rates for the most deadly gynecological cancer in the United States.
Genzyme, a Sanofi company, announced today that the U.S. Food and Drug Administration (FDA) has accepted for review the company's resubmission of its supplemental Biologics License Application (sBLA) seeking approval of LemtradaTM (alemtuzumab) for the treatment of relapsing forms of multiple sclerosis.
› Verified 7 days ago
Stacey C Dostie, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 35 Medical Center Pkwy, Augusta, ME 04330 Phone: 207-622-1959 Fax: 207-430-4007 | |
Vanessa Railton, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 35 Medical Center Pkwy, Augusta, ME 04330 Phone: 207-622-1959 Fax: 207-430-4007 | |
Elisha Rose Coppens, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 35 Medical Center Pkwy # Pa, Augusta, ME 04330 Phone: 207-622-1959 Fax: 207-430-4007 | |
Sharon A Paradis, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 6 E Chestnut St, Augusta, ME 04330 Phone: 207-622-1959 Fax: 207-622-1959 | |
Ms. Edith June St. Pierre, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 1 Va Ctr, Augusta, ME 04330 Phone: 207-623-8411 Fax: 207-621-4890 | |
Dana Jo Marshall, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 35 Medical Center Pkwy, Ste 201, Augusta, ME 04330 Phone: 207-622-1959 Fax: 207-430-4007 | |
Michael J Jose, C.R.N.A. Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 35 Medical Center Pkwy Ste 201, Augusta, ME 04330 Phone: 207-622-1959 Fax: 207-430-4007 |